Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 89 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $8,267 | -91.2% | 1,694 | -74.0% | 0.00% | -100.0% |
Q3 2022 | $94,000 | -5.1% | 6,513 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $99,000 | +350.0% | 6,513 | +248.7% | 0.00% | – |
Q1 2022 | $22,000 | -26.7% | 1,868 | 0.0% | 0.00% | – |
Q4 2021 | $30,000 | -43.4% | 1,868 | 0.0% | 0.00% | – |
Q3 2021 | $53,000 | -42.4% | 1,868 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $92,000 | +27.8% | 1,868 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $72,000 | +148.3% | 1,868 | +178.4% | 0.00% | – |
Q2 2020 | $29,000 | – | 671 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
Artal Group S.A. | 400,000 | $1,952 | 0.11% |
Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
XTX Topco Ltd | 38,574 | $188,241 | 0.04% |